Healthcare Companies By Pb Ratio

Price To Book
Price To BookEfficiencyMarket RiskExp Return
1VSEE VSee Health,
359.54
 0.07 
 6.83 
 0.46 
2HCA HCA Holdings
293.44
(0.07)
 1.69 
(0.12)
3HURA TuHURA Biosciences
146.92
 0.03 
 10.84 
 0.36 
4GH Guardant Health
55.67
 0.30 
 4.60 
 1.38 
5LLY Eli Lilly and
50.78
 0.03 
 2.15 
 0.06 
6DVA DaVita HealthCare Partners
36.86
 0.22 
 1.56 
 0.35 
7BSGM BioSig Technologies, Common
36.58
(0.04)
 9.44 
(0.36)
8NTRA Natera Inc
26.49
 0.18 
 3.66 
 0.67 
9IDXX IDEXX Laboratories
21.19
 0.03 
 1.52 
 0.05 
10TLX Telix Pharmaceuticals Limited
20.71
 0.14 
 2.83 
 0.40 
11WAT Waters
14.97
 0.08 
 1.76 
 0.14 
12PACS PACS Group,
11.04
(0.19)
 6.06 
(1.12)
13WGS GeneDx Holdings Corp
10.46
 0.04 
 4.67 
 0.17 
14MDCX Medicus Pharma Ltd
9.2
(0.06)
 9.64 
(0.58)
15NSRS North Springs Resources
8.51
 0.00 
 0.00 
 0.00 
16SHC Sotera Health Co
8.4
(0.09)
 2.07 
(0.19)
17NIVF NewGenIvf Group Limited
7.91
(0.10)
 10.81 
(1.10)
18BSX Boston Scientific Corp
7.31
 0.29 
 1.16 
 0.34 
19SYK Stryker
7.23
 0.09 
 1.26 
 0.12 
20A Agilent Technologies
7.12
 0.10 
 1.50 
 0.15 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities. Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.